Investors Fight Keryx Bid To Ditch Kidney Drug Stock Case
By John Petrick ( March 14, 2019, 4:43 PM EDT) -- Shareholders of Keryx Biopharmaceuticals Inc. told a Massachusetts federal judge Wednesday that the drug company's latest attempt to ditch claims it hid potential snags in the manufacturing of its drug Auryxia from shareholders is a rehash of old arguments already rejected by the court....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.